Scientists may one day be able to help thousands of people in Britain with an inherited condition that leads to the loss of sight, after partially curing blind mice and dogs.
The study found that congenitally blind mice and dogs with a condition similar to the condition retinitis pigmentosa could regain some vision following therapy based on the addition of a human gene that enabled cells in the retina to become sensitive to light.
Retinitis pigmentosa involves the progressive loss of both kinds of photoreceptors in the retina - the rods and the cones - usually from the edge to the centre, leading to worsening tunnel vision caused by the loss of peripheral sight.
However, in addition to rods and cones there are other cells in the retina - called the ganglion and the bipolar cells - that can remain undamaged. The researchers used gene therapy to convert these cells to light-sensitive photoreceptors by inserting an additional gene for a protein known as an "ion channel" which helps to convert light into a nerve impulse.
Once the scientists had converted millions of retinal cells by gene therapy, they injected another chemical known as a "photoswitch" into the eye, which attached itself to the ion channel protein, enabling the full conversion of light into an electrical signal relayed to the brain.